IMMUNOCHEMICAL DETECTION OF INDUCIBLE NO SYNTHASE IN HUMAN LUNG

被引:89
作者
TRACEY, WR [1 ]
XUE, C [1 ]
KLINGHOFER, V [1 ]
BARLOW, J [1 ]
POLLOCK, JS [1 ]
FORSTERMANN, U [1 ]
JOHNS, RA [1 ]
机构
[1] UNIV VIRGINIA,HLTH SCI CTR,DEPT ANESTHESIOL,CHARLOTTESVILLE,VA 22908
来源
AMERICAN JOURNAL OF PHYSIOLOGY | 1994年 / 266卷 / 06期
关键词
NITRIC OXIDE SYNTHASE; MACROPHAGE; CYTOKINE; PULMONARY; BRONCHIECTASIS; PNEUMONIA; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; ADULT RESPIRATORY DISTRESS SYNDROME; INFLAMMATION; LIVER;
D O I
10.1152/ajplung.1994.266.6.L722
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Type II (inducible) nitric oxide synthase (NOS) may play an important role in pulmonary pathophysiology, yet it remains controversial whether human tissues are capable of expressing this protein. Therefore, a polyclonal antibody (8196) was raised against type II NOS from induced RAW 264.7 macrophages and used to investigate the expression of this enzyme in human lung tissue. Anti-type II NOS antibody did not cross-react with either neuronal (type I) or endothelial (type III) constitutive NOS, whereas a 130-kDa protein was detected in cytosol from induced macrophages or liver removed from lipopolysaccharide (25 mg/kg)-treated rats. Cells or tissues that lacked NOS activity did not express immunoreactive proteins. Similarly, in grossly normal human lung tissue, no immunoreactivity was detected with the anti-type II NOS antibody. In contrast, strong immunoreactivity was detected in alveolar macrophages present in lung tissue from a patient with bronchiectasis and acute bronchopneumonia. These data demonstrate that human alveolar macrophages are able to express type II NOS and support a role for this enzyme in pulmonary inflammatory pathophysiology.
引用
收藏
页码:L722 / L727
页数:6
相关论文
共 31 条
[11]   EVIDENCE FOR CYTOKINE-INDUCIBLE NITRIC-OXIDE SYNTHESIS FROM L-ARGININE IN PATIENTS RECEIVING INTERLEUKIN-2 THERAPY [J].
HIBBS, JB ;
WESTENFELDER, C ;
TAINTOR, R ;
VAVRIN, Z ;
KABLITZ, C ;
BARANOWSKI, RL ;
WARD, JH ;
MENLOVE, RL ;
MCMURRY, MP ;
KUSHNER, JP ;
SAMLOWSKI, WE .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (03) :867-877
[12]   NITRIC-OXIDE - A CYTO-TOXIC ACTIVATED MACROPHAGE EFFECTOR MOLECULE [J].
HIBBS, JB ;
TAINTOR, RR ;
VAVRIN, Z ;
RACHLIN, EM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 157 (01) :87-94
[13]   MODULATION OF ACUTE-INFLAMMATION BY ENDOGENOUS NITRIC-OXIDE [J].
IALENTI, A ;
IANARO, A ;
MONCADA, S ;
DIROSA, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 211 (02) :177-182
[14]   ENDOTHELIUM-DEPENDENT RELAXATION AND CYCLIC-GMP ACCUMULATION IN RABBIT PULMONARY-ARTERY ARE SELECTIVELY IMPAIRED BY MODERATE HYPOXIA [J].
JOHNS, RA ;
LINDEN, JM ;
PEACH, MJ .
CIRCULATION RESEARCH, 1989, 65 (06) :1508-1515
[15]   L-ARGININE-DEPENDENT PRODUCTION OF NITROGEN-OXIDES BY RAT PULMONARY MACROPHAGES [J].
JORENS, PG ;
VANOVERVELD, FJ ;
BULT, H ;
VERMEIRE, PA ;
HERMAN, AG .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 200 (2-3) :205-209
[16]   NITRIC-OXIDE SYNTHASE IN HUMAN AND RAT LUNG - IMMUNOCYTOCHEMICAL AND HISTOCHEMICAL-LOCALIZATION [J].
KOBZIK, L ;
BREDT, DS ;
LOWENSTEIN, CJ ;
DRAZEN, J ;
GASTON, B ;
SUGARBAKER, D ;
STAMLER, JS .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1993, 9 (04) :371-377
[17]   ACTIVATED MACROPHAGES KILL PANCREATIC SYNGENEIC ISLET CELLS VIA ARGININE-DEPENDENT NITRIC-OXIDE GENERATION [J].
KRONCKE, KD ;
KOLBBACHOFEN, V ;
BERSCHICK, B ;
BURKART, V ;
KOLB, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 175 (03) :752-758
[18]   CLEAVAGE OF STRUCTURAL PROTEINS DURING ASSEMBLY OF HEAD OF BACTERIOPHAGE-T4 [J].
LAEMMLI, UK .
NATURE, 1970, 227 (5259) :680-+
[19]   TISSUE-INJURY CAUSED BY DEPOSITION OF IMMUNE-COMPLEXES IS L-ARGININE DEPENDENT [J].
MULLIGAN, MS ;
HEVEL, JM ;
MARLETTA, MA ;
WARD, PA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (14) :6338-6342
[20]   L-ARGININE DEPENDENT REACTIVE NITROGEN INTERMEDIATES AND THE ANTIMICROBIAL EFFECT OF ACTIVATED HUMAN MONONUCLEAR PHAGOCYTES [J].
MURRAY, HW ;
TEITELBAUM, RF .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (03) :513-517